Post Date: July 2, 2020
Daniel Starczynowski, PhD, has been selected as one of nine scientists nationwide to receive grant funding from a nearly $7 million fund launched by three philanthropic organizations.
The Blood Cancer Discoveries Grant Program was announced July 1, 2020, by the Leukemia & Lymphoma Society (LLS), the Mark Foundation, and the Paul G. Allen Frontiers Group. The fund’s goal: “to encourage researchers with deep experience in the blood cancers to conduct critical basic research in hopes of unleashing the next wave of novel approaches to treating leukemia, lymphoma, myeloma and myelodysplastic syndromes.”
Each researcher was awarded a three-year $750,000 grant.
Starczynowski’s project will investigate the role and potential benefit of therapeutic targeting of a protein called UBE2N in acute myeloid leukemia (AML).
Starczynowski is a member of the Division of Experimental Hematology & Cancer Biology at Cincinnati Children’s and the Katherine Stewart Waters Endowed Chair of Hematologic Malignancies.
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.